“…Serving as the primary target for most clinical opioids, the OPRM1 gene has been considered as the predominant genetic candidate responsible for vulnerability to opioid dependence (Bond et al, 1998;Uhl et al, 1999;Hoehe et al, 2000;Luo et al, 2003;Ikeda et al, 2005;, as well as dependence on other substances of abuse, such as alcohol and nicotine (Kim et al, 2004;Lerman et al, 2004;Ray and Hutchison, 2004;Berrettini and Lerman, 2005;Zhang et al, 2006a). Of the 4536 single nucleotide polymorphisms (SNPs) in the human OPRM1 gene identified in the dbSNP database, rs1799971 (A118G) has been the most extensively studied in association with dependence and addiction to drugs of abuse, such as heroin.…”